Egypt Syringes, Auto Disable Syringe and IV Cannulas Market is Expected to Grow at 4.6% in the Forecast Period of 2021 to 2028

Egypt Syringes, Auto Disable Syringe and IV Cannulas Market is forecast to grow at 4.6% with factor such as advancements in imaging technologies.

The rising incidence of various infectious diseases, emergence of novel health conditions such as the COVID-19 and increase in awareness around preventive healthcare have led to the increasing usage of Syringes.

Syringes, Auto Disable Syringe and IV Cannulas Market Scenario

According to Data Bridge Market Research, the market leader for syringes, auto disable syringe and IV cannulas in Egypt is BD, which accounts an estimated market share of 20% to 30%. The company is engaged in the development, manufacturing and sale of wide range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For instance,

  • In January 2021, syringe manufacturer BD has negotiated with the U.S. government to supply 286 million syringes for use with COVID-19 vaccines including about 40 million low dead space syringes and is completely prepared to comply with this arrangement. This will boost the supply chain of the company.

Egypt Syringes, Auto Disable Syringe and IV Cannulas Market

Trends Impacting the Market

The syringes, auto disable syringe and IV cannulas market is becoming more competitive every year with companies such as BD, ElArabi Pharma Group and AMECO as they are the market leaders for Egypt syringes, auto disable syringe and IV cannulas market. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the syringes, auto disable syringe and IV cannulas market.

For more analysis on the syringes, auto disable syringe and IV cannulas market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=egypt-syringes-auto-disable-syringe-and-iv-cannulas-market

Syringes, Auto Disable Syringe and IV Cannulas Market Development in 2020

  • In February 2021, Polymedicure's QIP committee approved allotment of 76,33,587 equity shares to eligible qualified institutional buyers at the issue price of Rs 524 per equity share, aggregating to Rs 400 crore. Polymedicure plans to use the net proceeds to support acceptable organic and inorganic development opportunities, continuing capital spending, other long-term and short-term provisions, prepayment and/or redemption of unpaid borrowings, general corporate intent or some other purpose as may be allowed under applicable legislation and approved by the Board of Director. This will help increase the net profit of the company.

Scopes of the Syringes, Auto Disable Syringe and IV Cannulas Market

All country based analysis of the global advanced wound care market is further analysed based on maximum granularity into further segmentation. On the basis of type, Egypt syringes market is segmented into general syringes, specialized syringes, and smart syringes. On the basis of usage, Egypt syringes market is segmented into reusable syringes and disposable syringes. On the basis of type, Egypt auto disable syringe and IV cannulas market is segmented into auto-disable syringes and IV cannulas. On the basis of type, Egypt IV therapy in IV cannulas market is segmented into central IV cannula, midline IV cannula, peripheral IV cannula. On the basis of material, Egypt auto disable syringe market is segmented into polypropylene barrel, rubber plunger, lubricant-silicone oil. On the basis of lock system, Egypt auto disable syringe market is segmented into barrel steal lock system and top plunger lock system. On the basis of volume, Egypt auto disable syringe market is segmented into 0.05ML, 0.1ML, 0.3ML, 0.5ML, 1ML, others. On the basis of gauge size, Egypt IV cannulas market is segmented into 14G TO 16G, 17G TO 20G, 22G TO 26G. On the basis of indication, Egypt auto disable syringe and IV cannulas market is segmented into vaccines, infectious diseases, inflammatory/auto-immune diseases, and others. On the basis of application, Egypt auto disable syringe and IV cannulas market is segmented into blood collection, vaccination, drug delivery and others. On the basis of end user, Egypt auto disable syringe and IV cannulas market is segmented into hospitals, clinics, research laboratories, ambulatory centers and others. On the basis of distribution channel, Egypt auto disable syringe and IV cannulas market is segmented into pharmacies, specialty stores, online and others.

To know more about the study https://www.databridgemarketresearch.com/reports/egypt-syringes-auto-disable-syringe-and-iv-cannulas-market

Key Pointers Covered in Syringes, Auto Disable Syringe and IV Cannulas Market Industry Trends and Forecast to 2028

  • Market Size
  • Market Standards and Changes
  • Market Trials in Different Regions
  • Market Requirements in Different Regions
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Recent Market Value for Different regions
  • Sales Data for Market Competitors
  • Market Key Vendors and Disruptors Study
  • Impact of COVID-19 in the Market

Key Market Competitors Covered in the Report

  • AMECO
  • ELDAWLIA 
  • Ultramedumic.
  • intermedica
  • Polymedicure
  • BD
  • ElArabi Pharma Group
  • AdvaCare Pharma
  • Sterimed Medical Devices Pvt. Ltd.
  • Denex International

Above are the key players covered in the report, to know about more and exhaustive list of syringes, auto disable syringe and IV cannulas market companies’, contact Us https://www.databridgemarketresearch.com/toc/?dbmr=egypt-syringes-auto-disable-syringe-and-iv-cannulas-market

Research Methodology

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Healthcare Professional, Doctors, Product Manufactures
  • Supply Side: Service Providers, Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/